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SifA is a Salmonella typhimurium effector protein
that is translocated across the membrane of the
Salmonella-containing vacuole by the Salmonella
pathogenicity island 2-encoded type III secretion sys-
tem. SifA is necessary for the formation of Salmonella-
induced filaments and for the maintenance of the vac-
uolar membrane enclosing the pathogen. We have
investigated the role of the C-terminal hexapeptide of
SifA as a potential site for membrane anchoring. An
S. typhimurium strain carrying a deletion of the se-
quence encoding this hexapeptide (sifA6) was found to
be attenuated for systemic virulence in mice. In mouse
macrophages, sifA6 mutant bacteria displayed a re-
duced association with vacuolar markers, similar to
that of sifA null mutant bacteria, and exhibited a dra-
matic replication defect. Expression of SifA in epithelial
cells results in the mobilization of lysosomal glycopro-
teins in large vesicular structures and Sif-like tubules.
This process requires the presence of the C-terminal
hexapeptide domain of SifA. Ectopic expression of trun-
cated or mutated versions of SifA affecting the C-termi-
nal hexapeptide revealed a strong correlation between
the membrane binding capability and the biological ac-
tivity of the protein. Finally, the eleven C-terminal res-
idues of SifA are shown to be sufficient to target the
Aequorea green fluorescent protein to membranes.
Altogether, our results indicate that membrane anchor-
ing of SifA requires its C-terminal hexapeptide domain,
which is important for the biological function of this
bacterial effector.
Salmonellae are the etiological agents of a variety of diseases
ranging from gastroenteritis to enteric fever. Salmonella typhi-
murium is the principal agent of food poisoning in humans and
causes a typhoid fever-like disease in mice and immuno-com-
promised humans (1, 2). Ingested S. typhimurium crosses the
intestinal epithelial barrier through M cells of Peyer’s patches
(3). Following invasion, the bacterium survives and replicates
within macrophages of the spleen and the liver (4, 5). Bacterial
multiplication within host cells is essential for virulence, be-
cause mutants defective for intracellular replication are atten-
uated in mice (6, 7). Intracellular replication of Salmonella
takes place in a membrane-bound compartment, the Sal-
monella-containing vacuole (SCV).1 Maintenance of the bacte-
ria within this vacuolar enclosure is a key aspect of the
virulence process (8, 9).
The nascent vacuole resulting from the bacterium internal-
ization is diverted from the phagocytic pathway and undergoes
a specific biogenesis process. The mature SCV is highly en-
riched in vacuolar ATPase and lysosomal membrane glycopro-
teins (Lgps) such as Lamp1, Lamp2, and CD 63 (10, 11). How-
ever, SCVs are essentially devoid of soluble lysosomal contents
(10, 12).
Intravacuolar bacterial replication initiates 3–5 h after in-
fection and correlates with the formation in epithelial cells of
unusual tubular membranous structures termed Sifs (for
Salmonella-induced filaments) (13). Sifs extend from and con-
nect SCVs and are characterized by a high enrichment in Lgps.
The formation of Sifs requires a functional type III secretion
system (TTSS) encoded by the Salmonella pathogenicity is-
land-2 (SPI-2) (8).
Several Gram-negative pathogens use TTSS to inject pro-
teins, termed bacterial effectors, into the host cell, were they
subvert specific host functions. SifA is a SPI-2 TTSS effector
(14) which is essential for Sif formation (15). In addition, sifA
mutant bacteria progressively lose their vacuolar membranes
in cultured macrophages and epithelial cells, as well as in
splenocytes in vivo (5, 8, 9). Mutation of sifA causes virulence
attenuation in mice and a strong replication defect in macro-
phages (8, 15–17). It is not known whether the absence of Sifs
and vacuolar membrane result from the same loss of function.
Other SPI-2 TTSS-translocated proteins, SseF, SseG and
SpiC, have also been found to be necessary for the formation of
Sifs (17). SpiC was originally described as an inhibitor of in-
teractions between SCV and late endocytic compartments (18).
SPI-2-encoded SseF and SseG are present on SCVs and Sifs
(19, 20). The role of these proteins in the biogenesis of Sifs
remains undetermined. PipB, SseJ, and SifB are other effector
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proteins secreted by the SPI-2 TTSS that have been found to
localize to Sifs and SCVs (20–22). Transfection of HeLa cells
with a plasmid encoding SifA fused to GFP complements the
defect of a sifA strain to induce Sif formation and maintain
the vacuolar membrane (8). Furthermore, expression of a
GFPSifA fusion protein in non-infected cells induces the vac-
uolation of Lamp1-positive compartments and the appearance
of tubular structures that resemble Sifs (16).
To gain some insight in the molecular mechanisms of action
of SifA, we analyzed the role of a C-terminal, cysteine-rich,
hexapeptide in the subcellular localization and biological func-
tion of this virulence factor. In the present paper, we show that
this domain is necessary for systemic virulence in mice, intra-
cellular replication, and reorganization of the host endocytic
compartment. Collectively, our results indicate that SifA re-
quires its C-terminal hexapeptide to achieve its function.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents—The rabbit antiserum against the Rab7
GTPase has been described previously (23). The mouse anti-Lamp1
H4A3 and rat anti-Lamp2 ABL-93 monoclonal antibodies, both devel-
oped by J. T. August, were obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the NICHD, National
Institutes of Health, and maintained by the University of Iowa (Depart-
ment of Biological Sciences, Ames, IA). Dr. S. Kornfeld (St. Louis, MO)
kindly provided rabbit polyclonal antibody against cathepsin D. Mouse
monoclonal anti-GFP antibody JL-8 was purchased from Clontech.
Polyclonal rabbit anti-S. typhimurium lipopolysaccharide was pur-
chased from Difco Laboratories. Goat anti-mouse peroxidase was pur-
chased from Sigma. The secondary antibodies Goat anti-rabbit, anti-rat
or anti-mouse IgG conjugated to Alexa 488, Alexa 594, or Alexa 680
were purchased from Molecular Probes.
Cell Lines and Culture Conditions—HeLa human epithelial cells and
RAW 264.7 mouse macrophage cells were routinely grown in Dulbecco’s
modified Eagle’s medium (DMEM; Invitrogen), supplemented with 10%
fetal calf serum (FCS, Life Technologies, Inc.), 2 mM glutamine, and
non-essential amino acids at 37 °C in 5% CO2.
Bacterial Strains—The S. typhimurium strains used in this work
were 12023 wild-type strain (NTCC), HH109 (ssaV::aphT) (24), P3H6
(sifA::mTn5) (8), and HH215 (sifA6). HH215 was constructed following
the method described in Ref. 25, using pKD4 as a template for PCR
amplification with SIFAD1 (5-GTT AAC CAC GCT ACA CGT TCG
CTC AGA ACA ACA AAG CGG CTA ATA AGT GTA GGC TGG AGC
TGC TTC-3) and SIFAD2 (5-GAC CGA TCA TTC AAG TTC CAC CTT
CTT ATT CAG AGG ATG GGG CAT ATG AAT ATC CTC CTT AG-3)
as primers, to generate a chromosomal deletion of sifA that lacks the
sequence encoding the C-terminal last six amino acids of the resulting
protein. The mutated gene was amplified by PCR, and the deletion
confirmed by sequencing.
Plasmid pFVP25.1, carrying gfpmut3A under the control of a consti-
tutive promoter, was introduced into bacterial strains for fluorescence
visualization (26). Bacteria were grown in Luria-Bertani (LB) medium
supplemented with ampicillin (50 g/ml), kanamycin (50 g/ml), or
chloramphenicol (50 g/ml) as appropriate.
Mouse Mixed Infections—Mice were inoculated intraperitoneally
with 105 colony-forming unit per mouse, as described previously (27).
The spleens were aseptically removed 48 h after inoculation, and bac-
teria recovered and enumerated after plating a dilution series onto LB
agar and LB agar with the appropriate antibiotics. Each competitive
index (CI) value is the mean of three independent mice infections and is
defined as the ratio between the mutant and wild-type strains within
the output (bacteria recovered from the mouse after infection) divided
by their ratios within the input (initial inoculum) (28, 29).
Bacterial Infection of HeLa Cells—HeLa cells were seeded onto glass
coverslips (12-mm diameter) in 10-cm dishes at a density of 106 cells per
dish 24 h before infection. Bacteria were incubated overnight at 37 °C
with shaking, diluted 1:33 in fresh LB broth and incubated in the same
conditions for 3.5 h. The cultures were diluted in Earle’s buffered salt
solution, pH 7.4 and added to the HeLa cells at a multiplicity of
infection of 100:1. The infection was allowed to proceed for 10 min at
37 °C in 7% CO2. Cells were washed three times with DMEM contain-
ing fetal calf serum (FCS) and 100 gml1 gentamicin and incubated in
this medium for 1 h, after which the gentamicin con centration was
decreased to 10 gml1.
Bacterial Infection of Macrophages and Survival Assays—Macro-
phages were seeded at a density of 105 cells per well in 24-well tissue
culture plates 24 h before use. Bacteria were cultured overnight at
37 °C with shaking. The cultures were opsonized in DMEM containing
FCS and 10% normal mouse serum for 20 min. Bacteria were added to
the cells at a multiplicity of infection of 100:1 and incubated for 20
min at 37 °C in 7% CO2. Macrophages were washed three times with
DMEM containing FCS and 100 gml1 gentamicin and incubated in
this medium for 1 h. The medium was replaced with DMEM containing
FCS and 10 gml1 gentamicin for the remainder of the experiment.
For enumeration of intracellular bacteria, macrophages were washed
three times with PBS and lysed with 0.1% Triton X-100 for 10 min, and
a dilution series was plated onto LB agar. Plates were incubated over-
night at 37 °C. Colonies were counted. Each time point was performed
in triplicate, and each individual experiment was performed three
times or more.
Expression of GFPSifA in HeLa Cells—The full sifA ORF was am-
plified from S. typhimurium genomic DNA by PCR using the primer 1
(5-AAA AAA GAA TTC CAC CAC CAT GCC GAT TAC TAT AGG GAA
TGG-3) and primer 2 (5-AAA AAA CCC GGG TTA TAA AAA ACA
ACA TAA ACA-3). The PCR product was subcloned into the unique
EcoR1 and XmaI sites of pEGF-C1 vector (Clontech) into the same
reading frame as EGFP, generating pgfp::sifA. The C-terminal deletion
or substitution mutants were generated using the primer 1 and second
primers designed so that they correspond to the different C-terminal
sequences. For fusing the 11 C-terminal residues of SifA to GFP, the
following primers (5-AATTCTGAACAACAAAGCGGCTGTTT ATGTT-
GTTTTTTATAG-3 and 5-GATCCTATAAAAAACAACATAAACAGC
CGCTTTGTTGTTCAG-3) were annealed and cloned into the EcoR1
and BamH1 sites of pEGFP-C1 generating GFPSifA-(326–336). HeLa
cells were transfected with FuGENE 6 (Roche Molecular Biochemicals)
following the manufacturer’s instructions. Cells were further incubated
for 24 h.
Immunofluorescence—Cells grown on coverslips were fixed with 3%
paraformaldehyde, pH 7.4, in PBS at room temperature for 10 min.
Fixed cells were washed three times in PBS and permeabilized by
incubating in PBS containing 0.1% saponin. Saponin 0.1% was included
in all subsequent incubation steps. Primary and secondary antibodies
were diluted in PBS containing 0.1% saponin and 5% normal horse
serum. Coverslips were incubated with primary antibodies for 20 min at
room temperature, washed in PBS containing 0.1% saponin, and then
incubated with appropriate Alexa goat secondary antibodies. Coverslips
were mounted onto glass slides using Mowiol (Aldrich). Cells were
observed with a Leica epifluorescence microscope or a confocal laser-
scanning microscope LSM510 Zeiss.
Subcellular Fractionation—For each chimeric GFP a 10-cm dish of
transfected HeLa cells was chilled on ice and washed three times in
ice-cold PBS. Scraped cells were pelleted for 5 min at 100  g in a
clinical centrifuge, overlaid with 3 ml of homogenization buffer (250 mM
sucrose, 3 mM imidazole, pH 7.4) and centrifuged for 5 min at 1800  g.
Cells were resuspended in 0.4 ml of homogenization buffer containing 1
mM phenylmethylsulfonyl fluoride and homogenized by three passages
through a 22-gauge needle. After centrifugation for 10 min at 1800  g,
the post-nuclear supernatant was collected and centrifuged at
100,000  g for 20 min. The soluble fraction was saved, and the pellet
was resuspended in a volume of homogenization buffer. For high pH
extraction, the pellet was resuspended in a volume of 100 mM NaOH,
pH 11, 50 mM NaCl, incubated for 15 min on ice, and centrifuged at
100,000 g for 20 min. Fractions were loaded on a 12% SDS-PAGE and
transferred on Immobilon-P for Western blotting.
RESULTS
A sifA6 Mutant Strain Is Attenuated in Mouse Virulence—
The C-terminal hexapeptide of SifA (CLCCFL) contains three
cysteine residues that may serve as recognition sites for lipi-
dations. These post-translational modifications are important
for membrane attachment and the biological functions of many
proteins. To investigate the role of the C-terminal hexapeptide
in the function of SifA, a mutant strain (HH215) was con-
structed carrying a deletion of sifA (sifA6) in the chromosome.
The truncated gene lacks the sequence encoding the C-terminal
last six amino acids of SifA. The virulence of this strain was
tested by comparing it with the wild-type strain in mixed
infections of mice. Bacteria from infected spleen were recovered
48 h after intra-peritoneal inoculation, and the competitive
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index was determined as described previously (30). The CI is a
sensitive measure of the relative degree of virulence attenua-
tion of a given mutant (27). The CI of the sifA6 mutant versus
the wild-type strains was significantly lower than 1.0 (CI 
0.226  0.08) showing that, in the mouse, the net growth of the
sifA6 mutant strain was considerably less than that of the
wild-type strain. This result indicates that the C-terminal
hexapeptide motif of SifA is required for full virulence in mice
and, therefore, SifA function.
A SifA6 Mutant Strain Has a Replication Defect in Macro-
phages—Because the sifA6 mutant strain is attenuated in the
systemic phase of the infection, and S. typhimurium systemic
virulence is correlated with its ability to replicate inside host
macrophages, this mutant strain was tested for replication over
16 h in the macrophage-like RAW 264.7 cell line. As a control
we used an ssaV mutant strain that is completely defective for
SPI-2-mediated secretion and, thus, defective for intracellular
replication (31, 32). We observed that the sifA6 mutant has a
replication defect similar to that of sifA and ssaV mutant
strains (Fig. 1A). This indicates that SifA-mediated prolifera-
tion in macrophages requires its C-terminal hexapeptide.
Loss of Vacuolar Membrane—SifA is essential to maintain
the integrity of the vacuolar membrane, as sifA mutant bac-
teria are gradually released into the host cell cytosol (8). The
cytosol of macrophages does not support S. typhimurium rep-
lication (9). Therefore it is possible that the failure of the sifA6
mutant strain to replicate inside these cells is due to a failure
to maintain the vacuolar membrane. To address this question,
we compared the level of association with an SCV membrane
marker, Lamp2, of sifA6 mutant bacteria to that of the wild-
type and sifA strain by immunofluorescence analysis. In
macrophages, 95% of wild-type and 47% of sifA bacteria were
decorated by the anti-Lamp2 antibody 10 h after bacterial
uptake. The sifA6 mutant displayed an intermediate pheno-
type with 70% of the bacteria found in association with the
membrane marker (Fig. 1B). Similar results were obtained in
bone marrow-derived macrophages (data not shown).
A drastic reorganization of Lgps to the vicinity of vacuoles
occurs in epithelial cells infected by S. typhimurium. This
process is dependent on the function of SifA (15, 22). In Raw
264.7 macrophages, a similar SifA-dependent phenomenon was
observed. Alteration of the distribution of Lamp2 was detected
in 65  6 or 5.5  0.7% of macrophages infected with wild-type
or sifA mutant bacteria, respectively (Fig. 1C). 27  3% of
macrophages infected with the sifA6 mutant strain exhibited
modified Lamp2 distribution (Fig. 1C). We concluded that the
maintenance of bacteria inside a vacuolar membrane and the
recruitment of Lgp-containing compartments require a full-
length SifA.
The C-terminal Domain of SifA Plays a Role in the Formation
of Sifs—The presence of Sifs is the hallmark of S. typhimurium
infection of epithelial cells (13), and the sifA gene is essential
for their formation (15). At 10 h after bacterial entry, Sifs were
detected in more than 65% of epithelial cells infected with the
wild-type strain, whereas the sifA mutant strain was unable
to induce the formation of such structures (Fig. 2A). The sifA6
mutant strain exhibited an intermediate phenotype, as Sifs
were found in 30% of infected cells (Fig. 2A). Where Sifs were
observed their morphology was altered, appearing shorter and
thinner (Fig. 2B). Therefore, we conclude that the C-terminal
hexapeptide motif of SifA contributes to the function of this
SPI-2 effector in remodeling intracellular compartments.
GFPSifA but Not GFPSifA6 Induces the Formation of En-
larged, Late Endosomal Vesicles and Sif-like Structures—Ec-
topic expression of SifA in epithelial cells complements the
failure of a sifA mutant strain to induce Sif formation (8) and
results, in non-infected cells, in the reorganization of late en-
docytic compartments (16). To investigate the specific contri-
bution of each of the six C-terminal residues to SifA function,
we generated a series of sifA alleles carrying deletions or sub-
stitutions in the sequence encoding the C-terminal region of the
protein and ligated them into a vector for transfection from
FIG. 1. A sifA6 mutant strain is defective for replication and
for association with Lamp2 in RAW 264.7 macrophages. Macro-
phages were allowed to phagocytose either opsonized wild-type (12023),
a SPI-2 secretion defective mutant (ssaV), sifA, or sifA6 bacteria
and were either lysed for enumeration of intracellular bacteria or fixed
and examined by epi or confocal fluorescence microscopy. A, this graph
shows the fold increase of various strains at 16 h post-uptake. The fold
increase was calculated as the number of intracellular bacteria at 16 h
after uptake divided by their number at 2 h. B, the graph shows the
percentage of bacteria associating with Lamp2 at 10 h post-uptake.
Results in panels A and B are the means  S.E. of three independent
experiments. C, confocal microscopic images of macrophages infected
with various strains expressing GFP (green) and immuno-labeled for
Lamp2 (red) show recruitment of cellular Lamp2 to vacuoles containing
wild-type but not to vacuoles containing sifA mutant bacteria. sifA6
mutant bacteria show an intermediate phenotype. Bar, 10 m.
FIG. 2. A sifA6 mutant strain is partially defective for Sif
formation in HeLa cells. Cells were infected with either wild-type
(12023), sifA, or sifA6 strains expressing GFP, fixed, and examined
by epi or confocal fluorescence microscopy. A, each S. typhimurium
strain was scored for its ability to induce Sif formation 10 h after
bacterial entry. Values are given as percentage of infected cells contain-
ing Sifs. Results are the means  S.E. of three independent experi-
ments. B, confocal microscopic images of representative examples of
cells infected with either wild-type or sifA6 strains. Sifs in cells in-
fected with the sifA6 mutant bacteria are shorter and thinner (arrows)
than in cells infected with wild-type strain. Bar, 10 m.
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which GFP-tagged versions of each proteins were expressed
(Fig. 3A).
Transfection of epithelial cells with a vector encoding
GFPSifA induces the formation of large Lgp-enriched vesicles
and filamentous structures resembling Sifs (16). Compared
with non-transfected cells (star symbol in Fig. 4A), we observed
similar large Lamp1-positive vesicles and tubules in cells ex-
pressing GFPSifA (Fig. 4A). Tubules were more numerous but
thinner than Sifs in infected cells (compare inset in Fig. 4A with
Fig. 2B) and will thereafter be referred to as Sif-like tubules.
Large Lgp-enriched vesicles and Sif-like tubules were observed
in 65 13% and 15 5%, respectively, of GFPSifA transfected
cells. GFPSifA co-localized with Lamp1 on vesicles and tubules
(Fig. 4A), and appeared essentially membrane bound.
To investigate the composition of the SifA-induced structures
in more detail, we examined the effect of ectopic expression of
these chimeras on the distribution of several other markers of
the endocytic pathway. EEA1, a marker for early endosomes,
was unaffected by the cellular expression of SifA (data not
shown). We also analyzed the effects on the distribution of late
endosomal (Rab7 and the cation-independent mannose
6-phophate receptor) and lysosomal (lysobisphosphatidic acid,
Lamp2, CD63, vATPase and cathepsin D) markers. In non-
transfected cells these two groups of markers were distributed
to distinct compartments, and no co-localization of late endo-
somal and lysosomal markers could be detected by confocal
microscopy (data not shown). In contrast, cells expressing
GFPSifA were characterized by the presence of both Rab7 and
cathepsin D in the large vesicular compartments in which they
co-localized with the over-expressed protein (Fig. 4B). This was
also the case for other late endosomal and lysosomal protein
and lipid markers (data not shown). Therefore, ectopic expres-
sion of SifA induces a profound reorganization of late endocytic
structures and results in the formation of an unusual vesicular
and tubular compartment.
We next examined the intracellular localization and the con-
sequences of the expression of GFPSifA6 in transfected cells.
Compared with cells expressing the full-length version of SifA,
a drastic reduction in the frequency of redistribution of Lamp1-
containing structures was observed, and Sif-like tubules were
very rarely seen (Fig. 3, B and C). Confocal imaging revealed
that the GFPSifA6 fusion protein was localized both in the
nucleus and the cytoplasm (Fig. 5), contrasting with the mem-
brane distribution of GFPSifA (Fig. 4). Therefore, we conclude
that both membrane association and SifA activity in trans-
fected cells are dependent on its C-terminal hexapeptide motif.
FIG. 3. C-terminal deletion and substitution mutants and their
effects on SifA activities. A, schematic representation of deletion and
substitution mutants of GFPSifA. The positions of cysteine-333 and
cysteine-334 and terminal leucine-336 residues are indicated. The num-
ber following the  symbol indicates the number of C-terminal residues
deleted. For GFPSifA(326–336), residues 326 to 336 corresponding to
the eleven C-terminal residues of SifA were fused to GFP. B and C,
mean values S.E. of three independent experiments where HeLa cells
(n  100 for each experiment) transfected with the various constructs
were scored for the presence of large Lamp1-positive vesicles (B) or the
formation of Sif-like tubules (C). Values are given as the percentage of
transfected cells displaying the phenotype.
FIG. 4. Ectopic expression of GFPSifA in HeLa cell induces the
reorganization of late endocytic compartment. HeLa cells tran-
siently expressing GFPSifA were fixed, immuno-labeled for various
markers, and observed by confocal microscopy. A, the color image shows
GFPSifA (green) transfected cells immuno-labeled for Lamp1 (red).
Gray scale images present GFPSifA and Lamp1 labeling of insets
magnified twice. GFPSifA induces the formation of large Lamp1-posi-
tive vesicles (top left inset) and the formation of Sif-like tubules (bottom
middle inset). For comparison, a non-transfected cell with a typical
lysosomal pattern for Lamp1 is marked (*). B, HeLa cells expressing or
not expressing GFPSifA and labeled for Rab7 or cathepsin D. Both
Rab7 and cathepsin D are present in GFPSifA-induced vesicles. Bar, 10
or 20 m for magnified insets.
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The C-terminal Domain of SifA Contains a Signal for Its
Association to Membranes—To gain insight in the function of
the C-terminal motif, the distribution of wild-type and mutant
versions of the GFP-tagged version of SifA between soluble and
membrane fractions of transfected cells was analyzed (Fig. 6).
GFPSifA was found to associate with the membrane fraction,
whereas the majority of GFPSifA6 was found in the cytosol
(Fig. 6A), consistent with fluorescence microscopic observations
(Fig. 5). Removal of the last or the last two amino acid residues
did not result in a significant change in the distribution of the
protein. By contrast, the deletion of the five C-terminal amino
acid residues rendered the protein mostly cytosolic (Fig. 6A).
The C-terminal hexapeptide of SifA contains three cysteine
residues, two of them being removed in the GFPSifA5 mutant
(Cys-333 and Cys-334, see Fig. 3A). To determine the relative
importance of each of these residues, we substituted each cys-
teine with serine, either individually or two at a time, and
tested their ability to mediate association with membranes in
transfected cells. We found that the membrane association of
the double C333S/C334S and both of the individual C333S and
C334S mutants was strongly reduced and comparable with
that of the GFPSifA5 mutant protein (Fig. 6C). We conclude
from these results that both Cys-333 and Cys-334 are required
for the membrane association of SifA.
Cysteine residues in position 333 and 334 could act as iso-
prenylation or palmitoylation sites. Such protein lipidations
stably anchor proteins to membranes, rendering them resistant
to extraction by alkali. To investigate the possibility that SifA
is tightly associated with membranes, membrane fractions
from cells expressing GFPSifA were treated with 0.1 M sodium
hydroxide. As shown in Fig. 6C, the membrane association of
GFPSifA resisted such high pH treatment. As expected, simi-
lar results were obtained for Rab7, which associates with mem-
branes by virtue of isoprenylation, whereas calreticulin, which
associates with membranes by binding to the KDEL receptor,
was extracted by this treatment (data not shown). These re-
sults suggest that SifA undergoes lipidation involving its cys-
teine residues.
The C-terminal Domain of SifA Is Sufficient to Target GFP to
Membranes—SifB is another S. typhimurium SPI-2 TTSS ef-
fector (20). In contrast to GFPSifA, GFPSifB was found to be
cytosolic upon expression in HeLa cells (data not shown). SifB
exhibits 26.4% identity to SifA over the length of the proteins.
However the last 11 amino acid residues of the C-terminal
domain of SifA are absent in SifB. To examine the effectiveness
of this domain as a membrane targeting signal, we fused the 11
C-terminal residues of SifA to GFP or GFPSifB, generating
GFPSifA-(326–336) (see Fig. 3A) or GFPSifBSifA-(326–336),
respectively. As shown in Fig. 7A, a fluorescence microscopic
observation of transfected HeLa cells revealed that GFPSifA-
(326–336) appeared to be essentially membrane associated
contrasting with the cytosolic distribution of GFP. Biochemical
analysis of fractionated transfected cells confirmed that
GFPSifA-(326–336) (Fig. 7B) and GFPSifBSifA-(326–336)
(data not shown) partitioned to the membrane fraction and
resisted to high pH extraction (data not shown). These exper-
iments demonstrate that the eleven C-terminal residues of SifA
are sufficient to target cytosolic proteins to membranes.
Membrane Association of SifA Is Required for Its Biological
Activity—Removal of the last or two last residues only slightly
reduced the biological activity of SifA, as measured by its
ability to induce formation of Lgp-enriched vesicles and Sif-like
tubules in transfected cells (Fig. 3, B and C). This ability was
greatly decreased when the C-terminal 5 residues were re-
moved. Interestingly, some residual activity was still detected
in cells transfected with GFPSifA5 that was consistently
higher than that detected in cells transfected with GFPSifA6.
Ectopic expression of SifA alleles carrying mutations in either
Cys-333, Cys-334, or both, induced residual reorganization of
Lgp-compartments in a manner similar to that induced in cells
expressing the GFPSifA5 mutant protein. These results es-
tablish a direct correlation between the membrane association
of the various deletion or substitution mutants and their ability
to reorganize late endocytic compartments. We conclude from
FIG. 5. GFPSifA6 does not alter the distribution of Lamp1 in
transfected cells. HeLa cells transiently expressing GFPSifA6 were
fixed, immuno-labeled for Lamp1, and observed by confocal microscopy.
Bar, 10 m.
FIG. 6. The C-terminal domain of SifA contains a signal for
membrane attachment. A and B, HeLa cells expressing either
GFPSifA or various deletion or substitution mutant in the C-terminal
domain of SifA were homogenized. Post-nuclear supernatants were
fractionated into membrane (M) and soluble (S) fractions, run on a
SDS-PAGE, and Western blotted with the use of a mouse monoclonal
anti-GFP antibody. C, total membranes of HeLa cells expressing
GFPSifA were extracted at high pH and fractionated again into ex-
tracted membrane (M ext) and extract fractions.
FIG. 7. The eleven C-terminal residues of SiFA are sufficient to
target GFP to membranes. Intracellular distribution of ectopically
expressed GFP or GFPSifA-(326–336) was observed by microscopy or
cellular fractionation. A, typical fluorescence microscopy images of
HeLa cells expressing each construct. Bar, 10 m. B, transfected cells
were homogenized. Post-nuclear supernatants were fractionated into
membrane (M) and soluble (S) fractions, run on a SDS-PAGE, and
Western blotted using a mouse monoclonal anti-GFP antibody.
GFPSifA-(326–336) is essentially membranous, whereas GFP is
cytosolic.
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these results that the biological activity of SifA depends on its
membrane binding capacity.
DISCUSSION
In the present paper we have investigated the structure-
function relationship of SifA. This Salmonella protein is syn-
thesized after bacterial entry into host cells and is translocated
across the vacuolar membrane into host cell membranes by the
SPI-2-encoded TTSS (8, 33). SifA was originally described as
essential for the formation of Sifs in epithelial cells (15). We
have previously shown that, in absence of this effector protein,
S. typhimurium is unable to preserve the integrity of the vac-
uolar membrane in which it is enclosed and is progressively
released into the host cytoplasm (8).
We are interested in understanding how SifA interferes with
the host cellular machinery. We hypothesize that SifA directly
competes with a host component. However, neither a BLASTp
against protein databases nor a search for proteins signatures
revealed significant similarities with eukaryotic proteins.
PSORT analysis of SifA revealed the presence, at the C termi-
nus, of a putative isoprenylation motif similar to those found on
Rab proteins (CAAX boxes are CC, CXC, CCXX, CCXXX; C is
cysteine, A is aliphatic and X can be any amino acid residue).
Rab GTPases are important regulators of different steps of
vesicular transport in eukaryotic cells (for review see Refs.
34–36). Isoprenylation is necessary for membrane binding and
biological activities of Rab proteins (37). Therefore, we were
interested in exploring the significance of this motif on a pro-
karyotic protein, SifA, which affects intracellular trafficking in
eukaryotic cells.
The functional importance of the C-terminal hexapeptide is
illustrated by the virulence attenuation of the sifA6 mutant
strain in the mouse model of systemic infection. In macro-
phages, the sifA6 mutant strain displayed a replication defect
comparable with that of the ssaV and sifA strains. In the
case of the sifA strain, this defect has been shown to be mainly
due to its inability to replicate into the macrophage cytosol (9).
Despite its strong replication defect, only 30% of sifA6 mutant
bacteria lost their vacuolar membranes. sifA mutant bacteria
that remain enclosed within a vacuole are still not capable of
replicating in either macrophages or epithelial cells (9), sug-
gesting that SifA function is also necessary for the maturation
of the SCV into a compartment that allows bacterial replica-
tion. Our results show that, beyond the phenotype of vacuolar
membrane loss, the sifA6 mutant strain has an additional
defect for replication inside the vacuole, suggesting that the
C-terminal hexapeptide is also necessary for SCV maturation
into a compartment permissive for replication.
In both macrophages and epithelial cells the late phase of
infection is marked by a dramatic redistribution of Lgps toward
the SCVs, as well as a disappearance of the vesicular pattern of
lysosomes. This SifA-dependent event is rarely observed in
macrophages infected with the sifA6 mutant strain. It sug-
gests that, in the absence of its C-terminal hexapeptide, SifA is
functionally defective. The low number of cells displaying Sifs
and their altered morphology in cells infected with the sifA6
mutant is likely to result from the same loss of function.
The functional defects observed with the sifA6 mutant
strain, are correlated with the failure of ectopically expressed
SifA6 to induce the reorganization of late endocytic compart-
ments that is observed in cells expressing the full protein.
GFPSifA induces the formation of large vesicles or large clus-
ters of vesicles that exhibit both late endosomal and lysosomal
markers. In contrast to what has been observed previously with
GFPSifA (16) we found that cathepsin D is present in
GFPSifA-induced vesicles. GFPSifA also induces the forma-
tion of Sif-like tubules. These are more numerous but thinner
than the Sifs found in infected epithelial cells. In cells express-
ing Lamp1GFP we have observed that lysosomes are very
dynamic organelles from which tubules are constantly forming,
growing, shrinking, and contacting other tubular or vesicular
structures. In contrast, in cells expressing Lamp1GFP and
infected with wild-type S. typhimurium, Sifs are essentially
non dynamic.2 The function of SifA could be to stabilize tubular
structures, therefore favoring membrane exchanges between
the SCV and host compartments. Large vesicles in SifA-ex-
pressing cells may result from unbalanced membrane ex-
changes between late endocytic structures.
GFPSifA is essentially membrane bound, whereas the func-
tionally inactive GFPSifA6 is cytosolic. Deletion mapping of
the C-terminal domain showed that a SifA mutant protein with
a deletion of the last two amino acid residues (GFPSifA2)
retains its membrane binding ability as well as full activity. In
contrast, deletion of the pentapeptide motif LCCFL as well as
the cysteine to serine substitution of residues 333 and 334
abolished both membrane association and biological functions
of SifA. Considering the homology of SifA C-terminal domain
with eukaryotic CAAX motifs, the crucial role of cysteine resi-
dues, and the ability of SifA to resist extraction by alkali, it
seems very likely that the cysteine residues 333 and 334 of SifA
are sites of lipidation.
To investigate further the contribution of the C-terminal
domain of SifA as a membrane targeting signal, its 11 C-
terminal residues were fused to the cytosolic proteins GFP and
GFPSifB. The rationale for this experiment is based on the
observation that the similarity between SifA and SifB excludes
the last 11 amino acids residues of SifA, which are absent in
SifB. The membranous localization of both GFPSifA (326–336)
and GFPSifBSifA (326–336) demonstrates that the 11 C-ter-
minal amino acid residues of SifA contain a signal that is
sufficient to target this protein to membranes. One can hypoth-
esize that this peptide sequence is either recognized by a mem-
brane receptor or contains a consensus sequences for lipidation.
Very short peptides containing consensus lipidation sequences
(4–16 amino acid residues) have been used to target various
GFP variants to membranes (38). The resistance of GFPSifA
and GFPSifA-(326–336) to alkali extraction and the specific
role of cysteine residues 333 and 334 in the partition of SifA are
consistent with the lipidation hypothesis. Indeed, the myris-
toylation of type III effector proteins from Pseudomonas syrin-
gae (a plant pathogen) by the host cell has been already re-
ported (39). Interestingly, myristoylation targets Avr proteins
to membranes, enhances their functions, and is required for
virulence. However, lipidation of SifA by the host cells remains
to be demonstrated.
Overall, our analysis of mutants shows that SifA must be
membrane-bound to be fully functional and has revealed a
crucial role of its C-terminal domain as a membrane-targeting
signal. Further work is needed to establish the molecular func-
tion of SifA and to understand how this function confers a
selective advantage to S. typhimurium within the host cell.
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